TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1626663

Group type: EXPERIMENTAL
Intervention: Propofol target concentration of 3 micrograms.ml‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol target concentration of 4 micrograms.ml‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol target concentration of 5 micrograms.ml‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol target concentrations (3, 4, 5 micrograms.ml‐1)
Number of subjects: 60
Study: 6334937

Group type: EXPERIMENTAL
Intervention: Electrotherapy using the Tenzcare Nr. 6240 apparatus
Number of subjects: 0
Study: 29130400

Group type: EXPERIMENTAL
Intervention: EBCT-R (Exposure-Based Cognitive Therapy for depression)
Number of subjects: 149

Group type: COMPARATOR
Intervention: CBT (Cognitive Behavioral Therapy)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Both EBCT-R and CBT
Number of subjects: 149
Study: 30509345

Group type: EXPERIMENTAL
Intervention: Transoral robotic surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional radiation therapy
Number of subjects: 0
Study: 26450911

Group type: COMPARATOR
Intervention: Treadmill walking with preferred walking speed (TPWS)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Floor walking with preferred walking speed (FPWS)
Number of subjects: 2
Study: 24764581

Group type: EXPERIMENTAL
Intervention: HLA-DPB1*04 (DP04)-binding NY-ESO-1157-170 peptide vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short 8-9-mer peptides
Number of subjects: 0

Group type: COMPARATOR
Intervention: Primaquine (inhibitor of endosomal recycling)
Number of subjects: 0
Study: 23254461

Group type: EXPERIMENTAL
Intervention: Standardized Korean ginseng berry (SKGB, 350 mg ginseng berry extract per tablet)
Number of subjects: 119
Study: 20585867

Group type: EXPERIMENTAL
Intervention: Neoadjuvant radiochemotherapy (5‐FU, cisplatin, 36 Gy)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 297
Study: 17846813

Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 33
Study: 16801310

Group type: EXPERIMENTAL
Intervention: Nucleotide supplemented formula (FN)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Regular formula (RF)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Breast-fed newborns (C)
Number of subjects: 21
Study: 14584060

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 0
Study: 10915847

Group type: EXPERIMENTAL
Intervention: PCR‐SSP method for genotyping MBL mutations
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: HY haplotype
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: LY haplotype
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: LX haplotype
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Structural variants B, C, and D
Number of subjects: 100
Study: 9264489

Group type: EXPERIMENTAL
Intervention: Mitral Regurgitation (MR) present
Number of subjects: 727

Group type: COMPARATOR
Intervention: No Mitral Regurgitation (MR)
Number of subjects: 727
Study: 8261826

Group type: EXPERIMENTAL
Intervention: Intraduodenal administration of 1 g/hr of fat
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intraduodenal administration of 2 g/hr of fat
Number of subjects: 6

Group type: COMPARATOR
Intervention: Hyperglycemia
Number of subjects: 6
Study: 3577269

Group type: EXPERIMENTAL
Intervention: Group B (rehabilitation patients)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Group A (control group)
Number of subjects: 110
Study: 29182458

Group type: EXPERIMENTAL
Intervention: Enhanced consent procedure (multimedia disclosure and corrective feedback)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Routine consent
Number of subjects: 248
Study: 27376872

Group type: EXPERIMENTAL
Intervention: RTG/EZG 600 mg/day
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: RTG/EZG 900 mg/day
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 25363099

Group type: EXPERIMENTAL
Intervention: Vitamin B1
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 22292673

Group type: EXPERIMENTAL
Intervention: Intratympanic (IT) steroid and hyperbaric oxygen (HBO) therapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Intravenous (IV) steroid and hyperbaric oxygen (HBO) therapy
Number of subjects: 48
Study: 20038718

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 17714541

Group type: EXPERIMENTAL
Intervention: Pasteurized own mother's milk
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Raw own mother's milk
Number of subjects: 2
Study: 15647927

Group type: EXPERIMENTAL
Intervention: APC8015 (Provenge) - an investigational therapeutic vaccine using autologous antigen presenting cells (APCs) loaded with a recombinant fusion protein of prostatic acid phosphatase.
Number of subjects: 0
Study: 12141813

Group type: EXPERIMENTAL
Intervention: GSAS (Gastroesophageal Reflux Disease Symptom Assessment Scale)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: SF‐36 Health Survey
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: GSAS and SF‐36 scales
Number of subjects: 187
Study: 8162730

Group type: EXPERIMENTAL
Intervention: Ipratropium (2 puffs via MDI; 36 micrograms)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Combination of albuterol and theophylline
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: All three drugs (ipratropium, theophylline, and albuterol)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Treatment groups
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Theophylline and albuterol
Number of subjects: 48
Study: 3065739

Group type: COMPARATOR
Intervention: prednisolone (PRD) plus chlorambucil (CLB) 5 days every 4 weeks
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: monthly intensive CHOP treatment
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 144
Study: 31199458

Group type: COMPARATOR
Intervention: Vitamin D2 (2.5 mg, total of four oral bolus doses over four months)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2.5 mg, total of four oral bolus doses over four months)
Number of subjects: 52
Study: 27463071

Group type: EXPERIMENTAL
Intervention: Integrated training group (ITG) - RMT using an incentive respiratory spirometer (IRS) and the abdominal drawing-in maneuver (ADIM)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: RMT group (RMTG) - RMT using an IRS
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (CG) - alternative and routine physical therapy or usual care
Number of subjects: 37
Study: 24850703

Group type: EXPERIMENTAL
Intervention: Triphala mouth rinse (aqueous)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chlorhexidine
Number of subjects: 60
Study: 24001084

Group type: EXPERIMENTAL
Intervention: fosphenytoin (fPHT)
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: levetiracetam (LVT)
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: valproic acid (VPA)
Number of subjects: 795
Study: 21574708

Group type: EXPERIMENTAL
Intervention: Lapse (smoking two cigarettes of their favored brand during a 30-min period)
Number of subjects: 63

Group type: COMPARATOR
Intervention: No lapse (a no-smoking control/30-min waiting period)
Number of subjects: 63
Study: 19336365

Group type: EXPERIMENTAL
Intervention: Newborn Individualized Developmental Care and Assessment Program
Number of subjects: 164

Group type: COMPARATOR
Intervention: Basic developmental care
Number of subjects: 164
Study: 16633798

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 15286526

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention (WINS trial)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Home healthcare by nurse or home health aide
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program (Multifit and Heart Smart)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Physical therapy
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Total monthly cost per woman
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Hospital admissions and physician and emergency-room visits
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Secondary prevention services
Number of subjects: 277
Study: 11408853

Group type: EXPERIMENTAL
Intervention: Polyglactin 910 mesh
Number of subjects: 161

Group type: COMPARATOR
Intervention: No mesh
Number of subjects: 161
Study: 8989344

Group type: EXPERIMENTAL
Intervention: 5 mg/d oral phylloquinone
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 2.5 mg/d oral phylloquinone
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 8515098

Group type: EXPERIMENTAL
Intervention: Rifampin (600 mg) plus ethambutol (25 mg/kg) plus ciprofloxacin (750 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 2971562

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (0.125 mg) inhaled
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (no drug, seated position)
Number of subjects: 13
Study: 31162803

Group type: COMPARATOR
Intervention: Nut consumption <1 time/week
Number of subjects: 23915

Group type: EXPERIMENTAL
Intervention: Nut consumption 1 time/week
Number of subjects: 23915

Group type: EXPERIMENTAL
Intervention: Nut consumption 2-3 times/week
Number of subjects: 23915

Group type: EXPERIMENTAL
Intervention: Nut consumption ≥4 times/week
Number of subjects: 23915
Study: 27422249

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 1044

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 1044
Study: 25174991

Group type: EXPERIMENTAL
Intervention: 8-week supervised exercise training programme (4 sessions per week)
Number of subjects: 39
Study: 24084327

Group type: EXPERIMENTAL
Intervention: GEN tacrolimus
Number of subjects: 126

Group type: COMPARATOR
Intervention: REF tacrolimus
Number of subjects: 126
Study: 22931614

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Tanshinone
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Clarithromycin + Tanshinone
Number of subjects: 255
Study: 19514614

Group type: EXPERIMENTAL
Intervention: losartan 50 mg once daily (in CORD IA)
Number of subjects: 4016

Group type: COMPARATOR
Intervention: ramipril 5 mg (n = 1,926)
Number of subjects: 4016

Group type: COMPARATOR
Intervention: losartan 50 mg (n = 1,887)
Number of subjects: 4016

Group type: COMPARATOR
Intervention: ramipril and losartan (CORD IB)
Number of subjects: 4016

Group type: COMPARATOR
Intervention: ramipril
Number of subjects: 4016
Study: 17463115

Group type: EXPERIMENTAL
Intervention: Computer-navigated total knee replacement
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional total knee replacement
Number of subjects: 71
Study: 15119886

Group type: EXPERIMENTAL
Intervention: Autogenous bone graft from mandibular symphysis
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Autogenous bone graft from ramus
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Autogenous bone graft from tuberosity
Number of subjects: 46
Study: 11499504

Group type: EXPERIMENTAL
Intervention: Two-implant overdenture treatment
Number of subjects: 24

Group type: COMPARATOR
Intervention: Four-implant overdenture treatment
Number of subjects: 24
Study: 9576150

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Inogatran
Number of subjects: 324
Study: 7889893

Group type: COMPARATOR
Intervention: Mixed oil rich in saturated fatty acids (SFA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Corn oil rich in n-6 fatty acids
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fish oil concentrate (MaxEPA) rich in n-3 fatty acids
Number of subjects: 12
Study: 2466315

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 29693749

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Various designs for examining treatment outcomes
Number of subjects: 0
Study: 28296730

Group type: EXPERIMENTAL
Intervention: CARE kV technique with SAFIRE reconstruction (value=3)
Number of subjects: 130

Group type: COMPARATOR
Intervention: 120 kV (control group)
Number of subjects: 130
Study: 26311549

Group type: EXPERIMENTAL
Intervention: Electrical stimulation and biofeedback treatment
Number of subjects: 324

Group type: COMPARATOR
Intervention: Pelvic floor muscle exercise at home (Control)
Number of subjects: 324
Study: 22952402

Group type: EXPERIMENTAL
Intervention: 1-piece MICS IOL (AF-1 NY-60, Hoya)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 3-piece MICS IOL (AF-1 iMICS Y-60H, Hoya)
Number of subjects: 40
Study: 20831669

Group type: EXPERIMENTAL
Intervention: 0.3% triclosan/2% copolymer dentifrice
Number of subjects: 120

Group type: COMPARATOR
Intervention: Fluoride dentifrice
Number of subjects: 120
Study: 19064823

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 11326

Group type: EXPERIMENTAL
Intervention: Metoprolol tartrate
Number of subjects: 11326

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 11326

Group type: COMPARATOR
Intervention: No β-blockers
Number of subjects: 11326
Study: 15964943

Group type: EXPERIMENTAL
Intervention: Adaptive servoventilation (ASV)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 25
Study: 12620164

Group type: EXPERIMENTAL
Intervention: Permethrin 5% cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metronidazole 0.75% gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10698027

Group type: EXPERIMENTAL
Intervention: 0.1% diclofenac
Number of subjects: 106

Group type: COMPARATOR
Intervention: 0.1% fluorometholone
Number of subjects: 106
Study: 8825812

Group type: EXPERIMENTAL
Intervention: GH 0.4 IU/kg/wk (D1)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: GH 1.2 IU/kg/wk (D2)
Number of subjects: 78

Group type: COMPARATOR
Intervention: GH 0.4 IU/kg/wk (D1) continued
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: GH 0.4 IU/kg/wk (D1) increased to 1.2 IU/kg/wk (D1D2)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: GH 1.2 IU/kg/wk (D2) continued
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: All groups (D1, D1D2, D2)
Number of subjects: 78
Study: 1318486

Group type: EXPERIMENTAL
Intervention: Albuterol (180 micrograms, inhaled)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 3901864

Group type: EXPERIMENTAL
Intervention: Stainless steel staples
Number of subjects: 195

Group type: COMPARATOR
Intervention: Polypropylene sutures
Number of subjects: 195

Group type: COMPARATOR
Intervention: Polyglactin sutures
Number of subjects: 195
Study: 30638271

Group type: EXPERIMENTAL
Intervention: Family-based behavioral treatment (FBT)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Parent-only variant of FBT (PBT)
Number of subjects: 150
Study: 30111467

Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 79

Group type: COMPARATOR
Intervention: Supine positioning
Number of subjects: 79
Study: 26340545

Group type: EXPERIMENTAL
Intervention: Intracoronary injection of CD133+ bone marrow stem cells
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 24268614

Group type: EXPERIMENTAL
Intervention: Cognitive Narrative Therapy (CNT)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Cognitive‐Behavioral Therapy (CBT)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Cognitive Narrative Therapy (CNT) and Cognitive‐Behavioral Therapy (CBT)
Number of subjects: 97
Study: 22855730

Group type: EXPERIMENTAL
Intervention: exendin‐(9‐39)
Number of subjects: 9

Group type: COMPARATOR
Intervention: vehicle
Number of subjects: 9
Study: 20421000

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Completion of combination therapy
Number of subjects: 20
Study: 17702270

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 0.5 mg/kg
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 15153888

Group type: EXPERIMENTAL
Intervention: Petrolatum‐delivering body wash applied with a polyethylene puff and 0.1% triamcinolone acetonide (medium strength corticosteroid)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Synthetic detergent bar soap applied with a washcloth and 0.05% fluocinonide (strong corticosteroid)
Number of subjects: 60
Study: 11799303

Group type: EXPERIMENTAL
Intervention: Iscador Quercus spezial(R) (IQ)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Iscador Pini(R) (IP)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (physiological saline solution)
Number of subjects: 48
Study: 9671836

Group type: EXPERIMENTAL
Intervention: Diatek 9000 Infrared Aural Thermometer
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: IVAC 2090 CoreCheck Tympanic Thermometer
Number of subjects: 137

Group type: COMPARATOR
Intervention: Oral electronic thermometer
Number of subjects: 137

Group type: COMPARATOR
Intervention: Conventional glass mercury thermometer
Number of subjects: 137
Study: 7719091

Group type: EXPERIMENTAL
Intervention: Intraperitoneal perfusion of compound injection of Salvia Miltiorrhiza before closing the abdominal cavity and Dachengqi decoction orally post-operatively
Number of subjects: 47

Group type: COMPARATOR
Intervention: Antibiotics intraperitoneally before closing the abdominal cavity
Number of subjects: 47
Study: 2680475

Group type: EXPERIMENTAL
Intervention: Five or more cups of coffee daily for 4 weeks
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Five or more cups of decaffeinated coffee daily for 4 weeks
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: No coffee for 4 weeks
Number of subjects: 54
Study: 59627

Group type: EXPERIMENTAL
Intervention: 5-azacytidine (200-250 mg/m2/day X 5 i.v.)
Number of subjects: 24

Group type: COMPARATOR
Intervention: guanazole (25-30 g/m2/day X 5 continuous i.v. infusion)
Number of subjects: 24
Study: 31351345

Group type: EXPERIMENTAL
Intervention: Twice-weekly clinic visits
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Fortnightly clinic visits
Number of subjects: 31

Group type: COMPARATOR
Intervention: Weekly clinic visits
Number of subjects: 31
Study: 27927734

Group type: EXPERIMENTAL
Intervention: Community-delivered hearing care intervention (HEARS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Delayed treatment group (waitlist control)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: HEARS intervention (pooled results)
Number of subjects: 15
Study: 25599378

Group type: EXPERIMENTAL
Intervention: Facebook Social Support Group
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard Walking Intervention
Number of subjects: 63
Study: 23548422

Group type: EXPERIMENTAL
Intervention: omega‐3 polyunsaturated fatty acids
Number of subjects: 120

Group type: COMPARATOR
Intervention: standard treatment of CHF
Number of subjects: 120
Study: 21651760

Group type: EXPERIMENTAL
Intervention: Short Term Psychodynamic Psychotherapy (STPP) with 25 individual sessions over 6 months
Number of subjects: 105

Group type: COMPARATOR
Intervention: Treatment as usual without specific training (control condition)
Number of subjects: 105
Study: 19349389

Group type: EXPERIMENTAL
Intervention: Video-assisted thoracic surgery (VATS) talc poudrage
Number of subjects: 60

Group type: COMPARATOR
Intervention: Talc slurry (TS) administered through a chest tube
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 16291715

Group type: EXPERIMENTAL
Intervention: Intravenous administration of escitalopram
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral administration of escitalopram (single or multiple doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral administration of escitalopram
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concurrent intake of food with escitalopram
Number of subjects: 0
Study: 12173165

Group type: EXPERIMENTAL
Intervention: Risk and resilience workshop
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Health information correspondence course
Number of subjects: 50
Study: 10547226

Group type: EXPERIMENTAL
Intervention: CVT-1 at doses of 0, 300, 1500, and 3000 mg/day
Number of subjects: 19

Group type: COMPARATOR
Intervention: CVT-1 at 1000 mg three times daily for 2 weeks
Number of subjects: 19
Study: 7799011

Group type: EXPERIMENTAL
Intervention: Eight-drugs-in-1-day chemotherapy
Number of subjects: 172

Group type: COMPARATOR
Intervention: Lomustine (CCNU), vincristine, and prednisone (control regimen)
Number of subjects: 172
Study: 2310659

Group type: EXPERIMENTAL
Intervention: Ritodrine
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 288486

Group type: EXPERIMENTAL
Intervention: Lithium carbonate, 300 mg t.i.d.
Number of subjects: 27

Group type: COMPARATOR
Intervention: No lithium
Number of subjects: 27
Study: 31585826

Group type: EXPERIMENTAL
Intervention: Cenegermin 20 μg/ml, 6 drops daily for 8 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Vehicle eye drops, 6 drops daily for 8 weeks
Number of subjects: 48
Study: 30680850

Group type: EXPERIMENTAL
Intervention: Upper thoracic spine intervention (passive mobilization)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Posterior shoulder intervention (massage, passive mobilization, and stretching)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Active control intervention
Number of subjects: 20
Study: 28359513

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 2331

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2331
Study: 25885585

Group type: EXPERIMENTAL
Intervention: Flexible belt
Number of subjects: 20

Group type: COMPARATOR
Intervention: Rigid belt
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 22664271

Group type: EXPERIMENTAL
Intervention: Transcranial ultrasound (TUS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21827933

Group type: EXPERIMENTAL
Intervention: Relaxation techniques for two months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no relaxation techniques)
Number of subjects: 0